Options to implement digital printing of medicines in clinical practice

The advantages of digital printing of medicines are obvious. With this technology, it is now possible to flexibly print the individually necessary and prescribed dose on demand. Several active ingredients can also be freely combined – compounded. The number of tablets a patient takes decreases, adherence and compliance increase. The process is also much more efficient and saves resources than pressing or encapsulating drugs.

Nevertheless, this innovation must be introduced and established safely and sustainably in the various markets. The conceivable approaches (studies, application in hospitals and in outpatient settings), supply contracts, reimbursement mechanisms and the financing of projects are the subject of the talk.

A presentation by professor Christian Franken, CEO, DIHESYS Digital Health Systems GmbH.

Interview

Question 1: What drives you?
Implementation of innovations that help patients

Question 2: Why should the delegate attend your presentation?
Interest in digital Health care solutions always helps. Interest in viable personalised medicine projects

Question 3: What emerging technologies / trends do you see as having the greatest potential in the short and long run?
Digital Printing, Gene/Bio Technology, Nanotech an robotic

Question 4: What kind of impact do you expect them to have?
Disruptive change of markets

Question 5: What are the barriers that might stand in the way?
Slow moving markets and fear of change

About Christian Franken
Christian Franken is pharmacist. Following his doctorate in pharmacology, he worked as a hospital pharmacist in different hospitals. He was chief pharmacist of the University Hospital Duesseldorf. He is specialist pharmacist for clinical pharmacy and drug information. From 2007 to 2020, he was chief pharmacist and board member at DocMorris. He is one ofe the founders of DiHeSys Digital Health Systems, of which he has been managing partner since 2020. He holds lectureships in Jena and Basel (Comparison of international healthcare systems), and he is an assistant professor at the Department of Clinical Pharmacology and Systems Medicine at Maastricht University.

About DIHESYS Digital Health Systems GmbH
DiHeSys – Digital Health Systems GmbH – an innovative, digital healthcare provider – with the goal of revolutionising healthcare through personalised medicine.
Through 2D and 3D printed medicines, we optimise the efficacy and tolerability of drugs for patients. DIHESYS provides the system containing GMP compliant hardware, software and Inks/filaments.

Christian Franken is speaker at the 2022 edition of the 3D Pharma Printing Conference.

Leave a Reply

Your email address will not be published.